" class="no-js "lang="en-US"> Angelini Pharma - Medtech Alert
Wednesday, September 03, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Angelini Pharma | Pharmtech Focus

Angelini Pharma

About Angelini Pharma

Angelini Pharma

Angelini Pharma is the pharmaceutical division of Angelini Group. The Group started almost 100 years ago as a small pharmaceutical laboratory, and over the years has grown into a leading international group in healthcare, present in Pharmaceuticals and Mass-Market.

Angelini Pharma is a leader in healthcare, with particular strength and expertise in the fields of Mental Health, including Pain, and Rare Diseases. The company is also a leading player in the Consumer Health segment, with highly successful OTC brands in Italy and abroad.

Related Story

Drug Development

 SK Biopharmaceuticals Partner Angelini Pharma Launches Cenobamate in France | PTF

SK Biopharmaceuticals' Partner Angelini Pharma Launches Cenobamate in France

December 9 2022

SK Biopharmaceuticals, an innovative global pharmaceutical company, announced that its European partner Angelini Pharma, an […]

Industry News

 Angelini Pharma and Trueblue: a new collaboration gets underway for optimising data-based decision making and analytics | Pharmtech Focus

Angelini Pharma and Trueblue: a new collaboration gets underway for optimising data-based decision making and analytics

February 10 2021

Promoting the development of corporate decision-making process powered by the use of data, KPIs and […]

Hero

 Angelini Pharma acquires Arvelle Therapeutics | Pharmtech Focus

Angelini Pharma acquires Arvelle Therapeutics

January 6 2021

Angelini Pharma, an international pharmaceutical company which is a part of the private Italian Angelini […]